SCHEMBL8782877

SCHEMBL8782877

NC(=O)NCCN(O)C(=O)/C=C/c1cccc(Oc2ccc(Cl)cc2)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 4/20 0.50
PTGS1 P23219 2/20 0.50
PTGS2 P35354 2/20 0.50
EPOR P19235 2/20 0.44
ALOX5AP P20292 1/20 0.43
MAPT P10636 2/20 0.41
ALDH1A1 P00352 2/20 0.41
MEN1 O00255 1/20 0.41
TP53 P04637 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41
HPGD P15428 1/20 0.41
ALOX15 P16050 1/20 0.41
TSHR P16473 1/20 0.41
ALOX12 P18054 1/20 0.41
NFKB1 P19838 1/20 0.41
MAPK1 P28482 1/20 0.41
CYP2C19 P33261 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8782799 1.00 ALOX5 (0.50) ALOX5PTGS1PTGS2EPORALOX5AP
SCHEMBL8782852 0.82 TLR4 (0.47) ALOX5PTGS1PTGS2EPORALDH1A1
SCHEMBL8942624 0.82 TLR4 (0.47) ALOX5PTGS1PTGS2EPORALDH1A1
SCHEMBL8942712 0.80 PARP14 (0.45) MEN1KMT2AP2RX3MMP1
SCHEMBL8782804 0.77 NPC1 (0.48) MAPTALDH1A1CYP1A2CYP2D6CYP2C9
SCHEMBL8782935 0.76 ALOX5 (0.47) ALOX5EPOR
SCHEMBL8783371 0.73 ALDH1A1 (0.57) ALOX5PTGS1PTGS2EPORALDH1A1
SCHEMBL8942607 0.73 ALDH1A1 (0.57) ALOX5PTGS1PTGS2EPORALDH1A1
SCHEMBL8783301 0.73 ALOX5 (0.47) ALOX5PTGS1PTGS2EPORALOX5AP
SCHEMBL8783296 0.73 ALOX5 (0.47) ALOX5PTGS1PTGS2EPORALOX5AP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0595995-B1 ARYLAMIDOALKYL- AND ARYLAMINOALKYL-N-HYDROXYUREA COMPOUNDS AND -N-HYDROXYFORMAMIDE DERIVATIVES HAVING LIPOXYGENASE INHIBITORY ACTIVITY ABBOTT LAB (US) 1997-01-15 EP disclosed
US-5514702-A Arylamidoalkyl-N-hydroxyurea compounds having lipoxygenase inhibitory activity ABBOTT LABORATORIES (US) 1996-05-07 US disclosed
EP-0595995-A4 ARYLAMIDOALKYL-N-HYDROXYUREA COMPOUNDS HAVING LIPOXYGENASE INHIBITORY ACTIVITY ABBOTT LAB (US) 1994-08-24 EP disclosed
EP-0595995-A1 ARYLAMIDOALKYL-N-HYDROXYUREA COMPOUNDS HAVING LIPOXYGENASE INHIBITORY ACTIVITY. ABBOTT LAB (US) 1994-05-11 EP disclosed
WO-1993002037-A1 ARYLAMIDOALKYL-N-HYDROXYUREA COMPOUNDS HAVING LIPOXYGENASE INHIBITORY ACTIVITY ABBOTT LABORATORIES (US) 1993-02-04 WO disclosed